Center-Authored Papers

Filters: Keyword is MART-1 Antigen  [Clear All Filters]
Journal Article
Yee C, Thompson JA, Byrd D, Riddell SR, Roche P, Celis E, Greenberg PD.  2002.  Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells.. Proceedings of the National Academy of Sciences of the United States of America. 99(25):16168-73. Abstract
Lee PP, Yee C, Savage PA, Fong L, Brockstedt D, Weber JS, Johnson D, Swetter S, Thompson J, Greenberg PD et al..  1999.  Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients.. Nature medicine. 5(6):677-85. Abstract
Abdul-Alim SC, Li Y, Yee C.  2010.  Conditional superagonist CTL ligands for the promotion of tumor-specific CTL responses.. Journal of immunology (Baltimore, Md. : 1950). 184(11):6514-21. Abstract
Yee C, Savage PA, Lee PP, Davis MM, Greenberg PD.  1999.  Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.. Journal of immunology (Baltimore, Md. : 1950). 162(4):2227-34. Abstract
Cohen JN, Guidi CJ, Tewalt EF, Qiao H, Rouhani SJ, Ruddell A, Farr AG, Tung KS, Engelhard VH.  2010.  Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation.. The Journal of experimental medicine. 207(4):681-8. Abstract
Liao X, Li Y, Bonini C, Nair S, Gilboa E, Greenberg PD, Yee C.  2004.  Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes.. Molecular therapy : the journal of the American Society of Gene Therapy. 9(5):757-64. Abstract